Geneos Wealth Management Inc. Bio Techne Corp Transaction History

Geneos Wealth Management Inc.

$2.77 Billion
Q4 2024

A detailed history of Geneos Wealth Management Inc. transactions in Bio Techne Corp stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 116 shares of TECH stock, worth $8,729. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116

Previous 116 -0.0%

Holding current value

$8,729

Previous $9,000 11.11%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$70.96 - $82.35 $8,231 - $9,552	116 New	116 $9,000
Q2 2022 Jul 22, 2022	SELL	$322.67 - $449.65 $645,340 - $899,300	-2,000 Closed	0 $0
Q2 2021 Jul 08, 2021	SELL	$387.35 - $450.26 $8,134 - $9,455	-21 Reduced 1.04%	2,000 $899,000
Q1 2021 Jun 17, 2021	SELL	$314.62 - $411.0 $629,240 - $822,000	-2,000 Reduced 49.74%	2,021 $863,000
Q4 2020 May 19, 2021	BUY	$246.9 - $321.87 $403,928 - $526,579	1,636 Added 68.6%	4,021 $1.52 Million
Q3 2020 Sep 07, 2021	SELL	$232.22 - $282.96 $232,220 - $282,960	-1,000 Reduced 29.54%	2,385 $576,000
Q4 2019 Sep 07, 2021	SELL	$189.68 - $222.09 $47,420 - $55,522	-250 Reduced 6.88%	3,385 $739,000
Q4 2018 Sep 07, 2021	SELL	$132.75 - $203.8 $7,301 - $11,209	-55 Reduced 1.49%	3,635 $515,000
Q1 2018 Sep 07, 2021	SELL	$131.46 - $151.04 $8,544 - $9,817	-65 Reduced 1.73%	3,690 $557,000
Q1 2017 Sep 07, 2021	SELL	N/A	-7 Reduced 0.19%	3,755 $381,000
Q3 2016 Sep 07, 2021	SELL	N/A	-23 Reduced 0.61%	3,762 $411,000
Q1 2016 Sep 07, 2021	BUY	N/A	3,785	3,785 $361,000

Others Institutions Holding TECH

# of Institutions

604

Shares Held

152M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.95B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Account

Geneos Wealth Management Inc. Bio Techne Corp Transaction History